5-159972203-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000679.4(ADRA1B):c.1274C>T(p.Ser425Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000955 in 1,361,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000679.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADRA1B | NM_000679.4 | c.1274C>T | p.Ser425Leu | missense_variant | 2/2 | ENST00000306675.5 | |
ADRA1B | XM_011534435.2 | c.1382C>T | p.Ser461Leu | missense_variant | 5/5 | ||
ADRA1B | XM_047416776.1 | c.1382C>T | p.Ser461Leu | missense_variant | 6/6 | ||
ADRA1B | XM_006714821.4 | c.950-13468C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADRA1B | ENST00000306675.5 | c.1274C>T | p.Ser425Leu | missense_variant | 2/2 | 1 | NM_000679.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000664 AC: 1AN: 150702Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000376 AC: 2AN: 53222Hom.: 0 AF XY: 0.0000634 AC XY: 2AN XY: 31568
GnomAD4 exome AF: 0.00000991 AC: 12AN: 1211228Hom.: 0 Cov.: 44 AF XY: 0.0000135 AC XY: 8AN XY: 592114
GnomAD4 genome AF: 0.00000664 AC: 1AN: 150702Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 73596
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.1274C>T (p.S425L) alteration is located in exon 2 (coding exon 2) of the ADRA1B gene. This alteration results from a C to T substitution at nucleotide position 1274, causing the serine (S) at amino acid position 425 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at